Delivery Order SPE2DB24D2205-SPE2DB25FEGVP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,108.47 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,791.04 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on August 5, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $11,112.30 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a completion date of July 31, 2025. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a $5,047.33 delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (90-count units) on August 18, 2025, with completion due by August 19, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical products to be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,801.47 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 30. This firm fixed price contract, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was not set aside for small business or other designated categories and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $5,056.95 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and was awarded on September 3, 2025. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, with a ceiling value of $1,041.18. The delivery order is for Terbinafine HCL 250 mg tablets in quantities of 30, an antifungal medication commonly used in military and federal healthcare systems. This is a firm fixed-price, non-set-aside award with an ultimate completion date of August 8, 2025, and...
- The Defense Logistics Agency awarded a delivery order valued at $34,163.11 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing contract vehicle. The award was made through open competition with no set-aside designation, and...
- The Defense Logistics Agency awarded a $3,616.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units) on September 18, 2025, with completion expected by September 19, 2025. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGVPDelivery Order
The Defense Logistics Agency awarded a $30,437.82 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count packaging) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement procedures to fulfill this pharmaceutical supply requirement for federal medical needs. The company maintains a substantial portfolio of federal contracts with DLA and serves critical roles in supplying medications to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for the antifungal medication reflects the ongoing pharmaceutical procurement demands of federal military and healthcare operations and demonstrates AmerisourceBergen's continued capability to meet federal medical supply requirements across competitive solicitations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.4k | 8/26/25 |